Arcellx (ACLX) EPS (Basic) (2021 - 2025)

Arcellx's (ACLX) quarterly EPS (Basic) came in at -$1.03 in Q4 2025, down 17.34% year-on-year from -$1.25 in Q4 2024, and down 4.54% quarter-over-quarter from -$0.99 in Q3 2025.

Arcellx (ACLX) EPS (Basic) (2021 - 2025) Analysis & Trends

Arcellx's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$1.03 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 17.34% year-over-year to -$1.03 in Q4 2025; TTM through Dec 2025 was -$4.06, a 102.96% decrease from a year earlier, with the FY2025 full-year figure at -$4.06, down 102.81% from the prior year.
  • EPS (Basic) fell to -$1.03 in Q4 2025 per ACLX's latest filing, from -$0.99 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.41 in Q4 2023 and bottomed at -$133.16 in Q4 2021.
  • The 5-year median for EPS (Basic) is -$0.96 (2025), against an average of -$12.53.
  • Across the five-year window, EPS (Basic) jumped 138.5% in 2023 and sank 725.98% in 2025, its largest moves.
  • Year by year, EPS (Basic) stood at -$133.16 in 2021, then surged by 99.19% to -$1.07 in 2022, then soared by 138.5% to $0.41 in 2023, then slumped by 312.71% to -$0.88 in 2024, then slipped by 17.34% to -$1.03 in 2025.
  • Per Business Quant, the three latest ACLX EPS (Basic) figures stand at -$1.03 (Q4 2025), -$0.99 (Q3 2025), and -$0.94 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.16
4 NuCana 279.75 Bn 279.75 Bn - 0.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.99
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Arcellx 6.48 Bn 6.48 Bn - -1.03

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.03
Sep 30, 2025 -0.99
Jun 30, 2025 -0.94
Mar 31, 2025 -1.13
Dec 31, 2024 -0.88
Sep 30, 2024 -0.48
Jun 30, 2024 -0.51
Mar 31, 2024 -0.14
Dec 31, 2023 0.41
Sep 30, 2023 -0.81
Jun 30, 2023 -0.50
Mar 31, 2023 -0.58
Dec 31, 2022 -1.07
Sep 30, 2022 -2.12
Jun 30, 2022 -0.84
Mar 31, 2022 -1.25
Dec 31, 2021 -133.16
Sep 30, 2021 -34.77
Jun 30, 2021 -36.43
Mar 31, 2021 -33.45